📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial. (2024)

First Author: Alagaratnam J

Attributed to: Blood-brain barrier dysfunction and risk of dementia following blood-stream infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jve.2024.100381

PubMed Identifier: 38988673

Publication URI: http://europepmc.org/abstract/MED/38988673

Type: Journal Article/Review

Volume: 10

Parent Publication: Journal of virus eradication

Issue: 2

ISSN: 2055-6640